Maanei hiki iā ʻoe ke ʻike i ka papa inoa o nā hui ʻo 10 Kina Biotech [Pharma] me nā kālā kālā, loaʻa a me ka ʻike o kēlā me kēia ʻoihana.
Papa inoa o nā hui 10 Kina Biotech [Pharma] kiʻekiʻe
No laila eia ka papa inoa o
1. ʻO Guangzhou Baiyunshan Pharmaceutical Group
ʻO Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. kahi hui i hoʻopaʻa ʻia e Guangzhou Pharmaceutical Group Co., Ltd. (He mau ʻāpana 600332, H mau ʻāpana 00874), i hana nui i:
- ʻO nā lāʻau lapaʻau Pākē a me ke Komohana, nā lāʻau kemika, nā lāʻau kūlohelohe, nā lāʻau olaola, nā mea waiwai R&D, ka hana ʻana a me ke kūʻai ʻana i nā mea waena;
- kūʻai nui, kalepa a lawe mai a hoʻokuʻu aku i nā lāʻau lapaʻau komohana, nā lāʻau lapaʻau Kina a me nā lako lāʻau lapaʻau;
- R&D, hana a kūʻai aku i nā huahana olakino nui; a
- ʻO nā lawelawe lapaʻau a me ka hoʻokele olakino, mālama olakino a me ka penikala a me nā ʻoihana olakino ʻē aʻe, etc.
Loaʻa i ka hui he 25 mau lāʻau lapaʻau nā hui hana a me nā ʻoihana (me 3 mau lālā, 19 mau lālā a me 3 hui hui pū), me 12 Kina manawa hanohano. mea lāʻau lapaʻau hui a me 10 mau hui kahiko; ʻO nā huahana lapaʻau Kina kūʻokoʻa Aia ma mua o 100 mau lula (me ka hoʻopaʻa ʻana i nā lālā a me nā ʻoihana hui).
- Loaʻa: CNY 79 Billion
Ma hope o nā makahiki o ke kūkulu pono ʻana a me ka hoʻomohala wikiwiki ʻana, ua hoʻokumu ka hui i ʻehā mau ʻāpana ʻoihana nui: "Great Southern Medicine", "Big Health", "Big Business" a me "Big Medical", a me "E-commerce", " Kapital Waiwai" a me "Nā Mea Lapaʻau". “ʻEkolu mau ʻano hou.
2. Hui Laau Laau Laau Lahui o Kina
ʻO China National Accord Medicines Corporation Ltd. kahi hui Kina i hoʻokumu nui ʻia i ka ʻoihana kūʻai nui, kūʻai kūʻai a me nā ʻoihana hana.
ʻO nā huahana koʻikoʻi o ka Hui e pili ana i nā hoʻomākaukau antibiotic, mana injections, antibiotic Active Pharmaceutical Ingredients (APIs), nā lāʻau lapaʻau ʻōnaehana hanu a me nā lāʻau ʻōnaehana cardiovascular a me cerebrovascular, a me nā mea ʻē aʻe.
- Loaʻa: CNY 67 Billion
Hoʻokomo pū ka Hui i ka hoʻolako ʻana i nā lawelawe logistic a me ka mālama ʻana, nā lawelawe hoʻolimalima a me nā lawelawe hoʻomaʻamaʻa, a me nā mea ʻē aʻe. Hāʻawi ka Hui i kāna mau huahana ma ka mākeke kūloko.
3. ʻO Kina Lapaʻau Lapaʻau
ʻO China National Pharmaceutical and Healthcare Industry Co., Ltd. he hui i hoʻopaʻa inoa ʻia e ka mokuʻāina i helu ʻia ma ka Shanghai Stock Exchange (puke kūʻai: China National Pharmaceutical; code stock: 600056).
ʻO ka mea kuleana mana ʻo China General Technology (Group) Holdings Co., Ltd. Me kahi kapikala i hoʻopaʻa ʻia he 1.068 biliona yuan, ʻo ka hui kekahi o nā ʻoihana kikowaena ʻekolu me ka lāʻau kūʻai lāʻau e like me kāna ʻoihana nui.
- Loaʻa: CNY 56 Billion
ʻO ka mea mua o Kina National Pharmaceutical ʻo ia ka China National Medicines and Health Products Import and Export Corporation ma lalo o ka Ministry of Foreign Trade and Economic Cooperation ma 1984.
ʻO ia ke kuleana o ka lāʻau lapaʻau a me nā huahana olakino e lawe mai a lawe aku i waho. Ua hui pū ʻo ia me China General Technology Group i ka makahiki 1999 a lilo ʻo ia i ʻāpana hoʻokahi o ka hui ma hope o ka hoʻonohonoho hou ʻana o ka lāʻau lapaʻau. waiwai i loko o ka hui.
4. Hale Hana La'au Lapa'au Nanjing
Ua ʻike mua ʻia ʻo Nanjing Pharmaceutical Factory Co. Ltd. ma 1935 a ʻo ia kekahi o nā mea hana nui ma National Pharmaceutical Industry. Ma hope o ka hoʻonohonoho hou ʻana o ka waiwai e Shenzhen Anyuan Investment Group ma 2000, lilo ʻo Nanjing Pharmaceutical Factory i hui lāʻau lapaʻau nui e hoʻohui i ka R&D, ka hana ʻana a me ke kūʻai aku ʻana i nā API (Active Pharmaceutical Ingredients), formulations a me nā waena.
Hoʻoponopono ka hoʻokele hou i ka laina huahana a me ka hoʻolālā hoʻomohala ʻana o ka ʻoihana, e mālama ana i ka ʻatikala "mālama i ke ola, hoʻokō i ke olakino", ʻo Nanjing Pharmaceutical Factoty e hoʻoikaika nui i ka hoʻomaikaʻi ʻana i ka maikaʻi o ke ola o ke kanaka a me ke olakino ma lalo o ke alakaʻi o "hoʻoponopono a hana hou”.
- Loaʻa: CNY 39 Billion
ʻO ka waihona hana APIs, e loaʻa ana ma Nanjing Chemical Industrial Park, he ʻeono mau mea kanu hana me nā hale hana kūikawā a me nā kumu he nui. Ua hala ka waihona i ka nānā ʻana i ka GMP aupuni a me ka honua i nā manawa he nui. Ma kahi kokoke i iwakālua mau ʻano API i kūʻai ʻia i nā mākeke kūloko a ma waho.
Loaʻa ka waihona kumu hana ma Nanjing Xingang Economic & Technological Development Zone, me ka hale hana injection (antineoplastic agents-based powder and ka wai nā injections) a me ka papa hana hoʻomākaukau waha (papa, capsules a me nā granules). Ua hala ke kumu i ka nānā ʻana i ka GMP aupuni i nā manawa he nui. ʻOi aku ma mua o iwakālua mau ʻano mea hoʻomākaukau i kūʻai ʻia ma Kina a puni.
5. Yunnan Baiyao
Ua hoʻokumu ʻia ʻo Yunnan Baiyao i ka makahiki 1902, kahi hōʻailona kaulana i Kina, a ʻo ia kekahi o ka pūʻulu mua o nā ʻoihana ʻenehana hou. He inoa kaulana ia no Kina ma ka home a ma waho.
Ma 1971, ua hoʻokumu ʻia ka hale hana e like me nā ʻōlelo a ke Kuhina Nui Zhou Enlai. I ka makahiki 1993, ua helu ʻia ma ka Shenzhen Stock Exchange ma ke ʻano he hui helu mua ma Yunnan.
- Loaʻa: CNY 32 Billion
- Kūkuluʻia: 1902
Hoʻokaʻawale nui ka hui i ʻehā mau ʻāpana nui: nā lāʻau lapaʻau, nā huahana olakino, nā kumu lāʻau lapaʻau Kina kuʻuna, a me nā logistic pharmaceutical.
He kūʻokoʻa kēlā me kēia māhele a kākoʻo kekahi i kekahi, e hoʻokumu ana mai ka hānau ʻana, ke kanu ʻana, ka noiʻi a me ka hoʻomohala ʻana, ka hana ʻana i ka ʻōnaehana waiwai mākeke o ke kaulahao ʻoihana holoʻokoʻa o nā huahana olakino a me nā lawelawe e hoʻokumu i kahi kaiaola waiwai me ka hoʻohui ʻana o nā ʻoihana kula kiʻekiʻe a me ka pono like. hoʻomohala ʻana i nā ʻāpana he nui.
6. Shandong Realcan Pūʻulu Lapaʻau
He hui ʻo Shandong Realcan Pharmaceutical Group e kūʻai aku i nā lāʻau lapaʻau, nā lāʻau lapaʻau, a me nā lāʻau lapaʻau i nā keʻena olakino ma ka ʻāina. Loaʻa iā ia ʻewalu mau ʻāpana lawelawe nui e pili ana i ka ʻenehana kālā, ka lāʻau lapaʻau Kina kuʻuna, ka lāʻau lapaʻau kikohoʻe, ka lāʻau hoʻonaʻauao lāʻau lapaʻau, ka loiloi loea, ka mea hana R&D a me ka hana ʻana, ka maʻi lapaʻau, a me ka hoʻohui ʻana i nā mea hana. Mea lawelawe lapaʻau.
Ua hoʻokumu ʻia ʻo Shandong Realcan Pharmaceutical Group ma Kepakemapa 21, 2004 me kahi kapikala i hoʻopaʻa ʻia he 1.5 biliona yuan. Loaʻa iā ia ma mua o 130 mau lālā a ʻoi aku ma mua o 12,000 limahana.
- Loaʻa: CNY 28 Billion
- Kūkuluʻia: 2004
- Nā limahana: 12000
Ua helu ʻia ka hui ma ka mākeke ʻo Shenzhen A-share ma Iune 2011 me ke code stock 002589. ʻO kāna pūnaewele kūʻai aku e uhi ana i nā panalāʻau 31 a me nā kūlanakauhale a puni ka ʻāina, e lawelawe pololei ana ma mua o 42,000 mau keʻena olakino, a ʻo kāna ʻoihana e uhi kokoke i nā mea hana hale a me nā haole ma luna. nui i koho ʻia.
7. ʻO Jiangsu Hengrui Pharmaceutical
ʻO Jiangsu Hengrui Pharmaceutical Co., Ltd. he hui lāʻau lapaʻau a olakino e hana nei i ka hana hou lāʻau lapaʻau a me ka R&D lāʻau kiʻekiʻe, hana a hoʻolaha.
Ua hoʻokumu ʻia ma 1970 a ua helu ʻia ma ka Shanghai Stock Exchange ma 2000. Ma ka hopena o 2019, ʻoi aku ka nui o nā limahana 24,000 ma ka honua holoʻokoʻa. He mea hoʻolako hale kaulana ia o nā lāʻau anti-tumor, nā lāʻau lapaʻau a me nā mea hoʻohālikelike, a ʻo ia hoʻi ke alakaʻi o ka National Anti-tumor Drug Technology Innovation Industry-University-Research Alliance.
- Loaʻa: CNY 26 Billion
Ua hoʻokumu ia i kahi National Targeted Drug Engineering Technology Research Center a me kahi keʻena noiʻi post-doctoral. I ka makahiki 2019, ua loaʻa i ka hui ka loaʻa kālā o 23.29 biliona yuan a me ka ʻauhau o 2.43 biliona yuan, a ua koho ʻia i ka papa inoa TOP50 o nā hui lāʻau lapaʻau honua, ka helu 47th.
I nā makahiki i hala iho nei, ua hoʻokomo ka hui ma kahi o 15% o kāna kūʻai aku i nā kālā noiʻi a me ka hoʻomohala. I ka makahiki 2019, ua hoʻolilo ʻo ia i ka huina o 3.9 biliona yuan i nā kālā noiʻi a me ka hoʻomohala ʻana, helu mahina no 16.7% o ka loaʻa kālā.
Ua hoʻokumu ka hui i nā kikowaena R&D a i ʻole nā lālā ma ʻAmelika Hui Pū ʻIa, ʻEulopa, Iapana, a me Kina, a ua kūkulu i kahi hui R&D ʻoi aku ma mua o 3,400 poʻe, ʻoi aku ma mua o 2,000 mau kauka, haku a ʻoi aku ma mua o 200 poʻe i hoʻi mai. I nā makahiki i hala iho nei, ua hana ka hui i 44 mau papahana kūikawā nui, a loaʻa iā 6 mau lāʻau lapaʻau hou, irecoxib, apatinib, thiopefilgrastim, pirotinib, carrelizumab a me toluene Remazolam acid i ʻae ʻia no ke kūʻai aku ʻana, aia kahi pūʻulu o nā lāʻau hou i lalo o ka hoʻomohala ʻana, a he ʻO ka nui o nā lāʻau lapaʻau hou e hoʻomohala ʻia ma ʻAmelika Hui Pū ʻIa.
Ua noi ka hui no ka huina o 894 mau palapala hoʻoheheʻe hale, loaʻa iā 201 mau palapala hoʻoheheʻe kūloko kūloko, a me 286 mau palapala ʻae ʻia e like me ʻEulopa, ʻAmelika a me Iapana. Ua lanakila kona ʻenehana koʻikoʻi i ka papa lua ʻelua National Science and Technology Progress Awards a me 2 China Patent Gold Award.
8. Pūʻulu Lapaʻau Renfu
Ua hoʻokumu ʻia ʻo Renfu Pharmaceutical Group Co., Ltd. ma 1993 a ua helu ʻia ma ka Shanghai Stock Exchange ma 1997 (600079.SH). ʻO ka ʻoihana lāʻau lapaʻau ʻo Hubei e alakaʻi ana i ka ʻoihana, ʻo Kina ʻoihana lāʻau lapaʻau kiʻekiʻe 100, National Science and Technology Innovation Demonstration Enterprise.
Hoʻopili ka hui i ka hoʻolālā o "ke alakaʻi i ka makeke lāʻau segment", a ua hoʻokumu i kahi kūlana alakaʻi i nā anesthetics home, analgesics, fertility regulators, Uyghur drugs and other sub-sectors; i ka manawa like, hoʻomohala ikaika ʻo ia i ka ʻoihana lāʻau lapaʻau a hoʻoikaika mau i ke kaʻina hana internationalization. , No ka hoʻokō ʻana i ka R&D honua, ka mākeke a me ka hoʻolālā ʻoihana ma ʻAmelika a me ʻApelika.
Ma ke ʻano he "Nationally Recognized Enterprise Technology Center" a me "National Major New Drug Development Project Undertaking Unit", ke koi nei ka hui i ka lawe ʻana i ka R&D ma ke ʻano he mea mua, a aia ma ke alo o ka hoʻopukapuka R&D a me ka holomua o ka lāʻau lapaʻau hou.
Ua hoʻokumu ʻia ma ka launa pū ʻana me ka Chinese Academy of Military Medical Sciences. ʻO Junke Optics Valley Innovative Drug R&D Center" i alakaʻi i ka hoʻokumu ʻana o ka "Hubei Biomedical Industry Technology Research Institute", i hoʻolaʻa ʻia no ke kūkulu ʻana i kahi papa hana hou lāʻau R&D hou.
9. Sichuan Kelun Pharmaceutical
ʻO Kelun kahi hui lāʻau lapaʻau kūikawā kūikawā a me ka loaʻa kālā kūʻai makahiki ma mua o 40 biliona yuan. Loaʻa iā Sichuan Kelun Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Research Institute Co., Ltd., Klus Pharma Inc. (Kelun, USA), a me KAZ Pharmaceutical Co., Ltd. (Kazakhstan Kelun), Sichuan Kelun Pharmaceutical Trading Co. ., Ltd. a ʻoi aku ma mua o 100 mau hui ma ka home a ma waho.
- Loaʻa: CNY 16 Billion
I ka makahiki 2017, ua helu ʻo Kelun i ka 155th ma waena o nā ʻoihana hana 500 kiʻekiʻe o Kina, a ʻo kona ikaika holoʻokoʻa i hoʻopaʻa ʻia ma waena o nā ʻekolu o ka ʻoihana lāʻau lapaʻau o Kina. Ma 2018, ua loaʻa ʻo Kelun ma ke ʻano he ʻoihana hōʻikeʻike poʻokela hoʻokahi i ka ʻoihana hana ma muli o kāna mau pono honua i nā injections nui. Ma 2020, ua loaʻa iā Kelun ka National Technology Innovation Demonstration Enterprise.
Ua hoʻopaʻa inoa maikaʻi ʻia ʻo Sichuan Kelun Pharmaceutical Co., Ltd. ma ka Shenzhen Stock Exchange i Iune 2010. I ka wā i hoʻolaha ʻia ai i ka lehulehu, ua hoʻolaha koke ʻo Kelun i nā ʻumi piliona o ka hoʻolālā hoʻopukapuka ʻoihana a hoʻomaka e hoʻokō i ka hoʻolālā hoʻomohala ʻana o "ʻekolu mau hanana i alakaʻi ʻia. , ulu hou.
10. ʻO Chongqing Zhifei Nā Huaola Ola
ʻO Chongqing Zhifei Biological Products Co., Ltd. ("Zhifei" a i ʻole "ka Hui" no ka pōkole) aia i loko o ka ʻoihana huahana biological ma 2002. Ua loaʻa i ka Hui kahi kālā hana o RMB10.59 biliona ma 2019 me ke kākoʻo o kāna kokoke. ʻO 3,000 mau limahana e pili ana i kāna kapikala i hoʻopaʻa inoa ʻia o RMB1.6 biliona a me nā waiwai āpau o RMB13.6 biliona.
I Kepakemapa 2010, ua helu ʻia ʻo Zhifei ma Shenzhen Stock Exchange (stock code: 300122), i lilo i ʻoihana kano kano mua i hoʻopaʻa ʻia ma ChiNext. He ʻelima mau lālā paʻa ʻia ʻo Zhifei a me kahi hui hui, ʻo Beijing ZhifeiLvzhu Biopharmaceutical Co., Ltd. a me Anhui ZhifeiLongcom Biopharmaceutical Co., Ltd. he mau ʻoihana ʻenehana kiʻekiʻe.
- Loaʻa: CNY 14 Billion
ʻO nā huahana kūʻai kūʻai ʻia o ka Hui ʻo Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) (Ekear®), Haemophilus Influenzae Type b Vaccine (XiFeiBei®), Group ACYW135 Meningococcal Polysaccharide Vaccine (Menwayc®), Mycobacterium Vaccae for Injection (Vaccae®), Meningococcal Group A a me Group C Polysaccharide Conjugate Vaccine (Mening A Con®), a me nā huahana kūʻokoʻa i kūkulu ʻia. I kēia manawa, ʻo Zhifei wale nō ka mea hāʻawi i nā lāʻau lapaʻau o Merck Sharp & Dohme (MSD) e like me HPV4 (Gradasil), HPV9 (Gradasil 9), 5-valent rotavirus vaccine (Rotateq), 23-valent Pneumonia vaccine (Pneumovax 23), Hepatitis He kano (Vaqta).
He pou blog maikaʻi loa ia. Heluhelu mau wau i kāu blog i nā ʻōlelo aʻoaʻo e kōkua ai a ʻike. Makemake wau iā ia no ka hāʻawi ʻana mai i kēia ʻike iā mākou
Nui moʻomanaʻo moʻomanaʻo. Kōkua kōkua a ʻike. Mahalo wau no ka hāʻawi ʻana i kēia ʻike me mākou
Mahalo no ke kaʻana like. E ho'āʻo wau e hoʻokō i kēia mau ʻano ma kaʻu blog. Mahalo no ke kaʻana like. E hoʻomau i ka hōʻano hou iā mākou.